HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan

Clinical trial NCT06236269 · RECRUITING

Trial details

NCT number: NCT06236269
Sponsor: SOLTI Breast Cancer Research Group
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Stage IV

Start date: 2024-03-15
Primary completion: 2026-02-20
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.